Best Oncological Check-up for Man Doctors in Israel — TOP 7

Dr. Ofer Merimsky heads the National Center for bone and soft tissue sarcomas at Sourasky Medical Center. He is a primary specialist in Israel for lung cancer and sarcoma treatment. Dr. Merimsky serves as Deputy Director of the Oncology Institute. He also specializes in complex Whipple surgery for pancreatic cancer cases. He works at JCI-accredited Sourasky Medical Center, ranked among the world's best hospitals by Newsweek.

• Former Chairman of the Oncology Department at Tel Aviv University.
• Past President of the Israeli Society for Medical Oncology and Radiation Therapy.
• Faculty member of the European Society for Medical Oncology (ESMO) for sarcomas.
• Completed specialized training in radiotherapy and brachytherapy at New York Hospital.

Dr. Nadir Arber heads the Integrated Cancer Prevention Center at Sourasky Medical Center. He specializes in the early diagnosis and treatment of gastrointestinal tumors. Dr. Arber has authored over 300 scientific papers on GI cancer research. He conducted research at the NewYork-Presbyterian Center in the United States.

• Expert in gene therapy for gastrointestinal cancers and inflammatory disorders.
• Treats complex GI conditions including esophageal, pancreatic, and colon cancers.
• Member of the American Association for Cancer Research.
• Practices at the JCI-accredited Sourasky Medical Center in Israel.

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Known Expertise 

Medical Oncologist 

Academic Position 

Senior Lecturer 

Education

Bar-Ilan University, Israel / Computational Biology 

Israeli Society for Health-Tech / Fellowship by IMA/ Innovation and Entrepreneurship in Medicine and Health-Tech 

Sheba Medical Center and Bar-Ilan University, Israel/ Genomics and Biomedical Informatics 

Semmelweis University/Doctor of Medicine 

Training and Specialization 

Clinical observership in acute oncology, early phase clinical trials and lung cancer/ Guy's and St. Thomas hospital, London, England 

Leader Shift, Executive Development Program, Tel-Aviv Sourasky Medical Center 

Fellowship Program in Innovation and Entrepreneurship in Medicine and Health-Tech 

Resident, Medical Oncology, TASMC, Israel 

6th year medical school rotations, Kaplan Medical Center, Israel 

Rotation, intensive care unit and pulmonology, Stony Brook hospital, NY, US 

Clinical Experience 

Leader of the TASMC oncology project of PSIFAS, the Israeli National Genomic Medicine Initiative 

PI for study initiator trial: T-Cell Repertoire sequencing as clinical efficacy tool for pembrolizumab (with platinum based chemotherapy) in advanced NSCLC. 

PI for study initiator trial: T-cell repertoire sequencing as a clinically efficacy tool for neoadjuvant immunotherapy plus platinum-doublet chemotherapy for resectable NSCLC. 

Representative of the National Medical Association for the National Council for the Prevention, Diagnosis and Treatment of Malignant Diseases, as well as head of the oncology field, Leumit HMO 

Consultant on drugs and operations in the field of oncology, Leumit HMO 

Member of the Helsinki Committee for Clinical Studies, TASMC 

Primary investigator (PI) in pharmaceutical phases I&III clinical trials Head of oncology day-care service, TASMC, Israel 

Molecular Tumor Board (MTB) moderator of the Israeli Lung Cancer Society 

NGS interpretation clinic alongside head of pathology, TASMC, Israel 

PI for study initiator trial: Genomic Variant of BCL-2 as a Novel Predictor of Response to Paclitaxel, TASMC, Israel 

Medical oncology clinic in the field of lung and breast cancer, TASMC, Israel

Leading sub-investigator (SI) in many phase I-III clinical trials in oncology, including intra-tumoral injections (mRNA, viruses and NO), TASMC, Israel 

Courses 

Good Clinical Practice ICH GCP R2 & Israeli MOH Guidelines Updated Course 

Point-of-Care Ultrasound course, Israeli Medical Association 

GCP training Bioforum 

GCP training Bioforum

Investigator Site Personnel ICH GCP Training Certificate - TransCelerate BioPharma 

Academic Experience 

Lecturer in the Department of Medical Education at the Faculty of Medical and Health Sciences at Tel Aviv University 

JIMS Journal Club - Instructor for students. 

Guidance of Dr. Aviv Berkovich M.D in basic science: cfDNA NGS for identification ofprimary and acquired resistance in patients with Lung Cancer and EGFR mutations. 

TASMC, Israel in collaboration with The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai, NY USA 

Training team for oncology residents, TASMC, Israel 

Mentor for new intern, TASMC, Israel 

Tutor for medical students in oncology clerkships, Tel-Aviv University, Israel 

Honors 

Outstanding teacher in the faculty of medicine, Tel-Aviv University, Israel

 Outstanding teacher in the faculty of medicine, Tel-Aviv University, Israel 

Sign of honor for reserve medical personnel for the battle in Lebanon, IDF

Completion of residency final examination (shlav Beit) with honors 

Israeli society for clinical oncology and radiation therapy (ISCORT) 17 research grant competition winner 

Affiliations 

Israeli Medical Association (IMA) 

Israeli Society for Clinical Oncology and Radiation Therapy (ISCORT) 

The Israeli Lung Cancer Group (ILCG) 

European Society of Medical Oncology (ESMO) 

International Association for the Study of Lung Cancer (IASLC) 

The International Society of Liquid Biopsy (ISLB) 

The Israeli Society for Health-Tech 

Boards 

Co-founder, board member and treasurer of the Israeli Acute Oncology Society 

Clinical Research Association Board of Directors on behalf of the Israeli Lung Cancer Group 

Member of the Trustees of Oncology Innovation, TASMC, Israel 

Doctor of Medical Service IDF 

Areas of interest 

Thoracic malignancies, 

early to late phase clinical trials, 

intra-tumoral injections, 

comprehensive genomic profiling of tumors, 

liquid biopsies: cfDNA, TCR rep-seq and epi-Genetics; 

cell therapy

Dr. Auala Hubert leads the Gastrointestinal Cancer Center at Hadassah Medical Center. He is a senior oncologist and radiotherapist specializing in digestive system malignancies. He graduated from Hadassah University Hospital in Jerusalem. Dr. Hubert has over 30 years of clinical experience in radiotherapy and oncology.

• Head of the Gastrointestinal Cancer Center at Hadassah.
• Treats complex conditions including pancreatic, colon, and liver cancers.
• Qualified in both medical oncology and radiotherapy.
• Member of the Israel Society of Clinical Oncology and Israel Cancer Association.

Dr. Rifaat Safadi heads the liver disease unit at Hadassah Medical Center. He specializes in treating cirrhosis, liver cancer, and complex gastrointestinal conditions. He completed a fellowship at the Sinai School of Medicine in New York. Dr. Safadi sits on the editorial board of Clinical Science journal.

• Winner of the Hadassah Prize for research in liver fibrosis.
• Treats patients at Hadassah Medical Center, ranked among the world’s best hospitals.
• Member of several international associations for the study of the liver.
• Performs liver resections and radioembolization for liver cancer.